… -19). Favipiravir is an antiviral … treatment of COVID-19. We aim to review existing favipiravir
safety evidence, which is vital to informing the potential future use of favipiravir in COVID-19. …

… severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), … disease caused by this
coronavirus, COVID-19. In this paper, … Also, the role of innate immune response to coronavirus …

… safety in the treatment of COVID-19; most of them are undergoing clinical trials. This article
summarizes clinical investigations of potential therapeutic drugs used as COVID-19 therapy. …

… options available, to consider the future of this global pandemic, and to identify some
potential options that could revolutionize the treatment of COVID-19. Moreover, this article …

… of COVID-19 based on its putative pathogenesis. The recent outbreak of COVID-19 has …
an exaggerated immune response very likely contribute to COVID-19 pathology. This leads to a …

… Up till now, a specific treatment for COVID-19 infection is not available. We believe that
new approaches to treatment should be considered in cases of COVID-19. Here, the …

… The current drugs approved by the Food and Drug Administration (FDA) for the treatment
of patients with COVID-19 prior to the writing of this manuscript are: Fresenius Medical, …

… and effective therapies for the COVID-19 is one of the major … pathological manifestations
of COVID-19 patients combined … a potential immunotherapy for the severe COVID-19 through …

… Therefore, in this article, new potential COVID-19 therapies are briefly reviewed. … potential
COVID-19 treatments can be essential and salvaging. In this article, new potential COVID-19 …

… treatment of COVID-19. As canakinumab and rilonacept are also IL-1 receptor antagonists,
they are also being evaluated in COVID-19 … for its potential impact on COVID-19 Similarly, …